Dr Reddy’s Laboratories failed to cheer the market despite June quarter net profit doubling. Analysts see concern over the US business and pressure on operating performance as key drags. These concerns have prompted traders to build bearish bets on the stock. Chandan Taparia, derivative analyst at Motilal Oswal, said the weakness could continue and the stock could drift down to Rs 3,950.
Kotak Mahindra Bank shares fall 4% to fresh 52-week low on another bad news
Kotak Mahindra Bank’s shares plummeted 4%, hitting a new 52-week low of Rs 1,561 following Joint MD KVS Manian’s resignation. Nuvama downgraded the stock from